Primary Care Clinics in Wheeler, TX Accepting Medicare
4 Primary Care Clinics found. Showing 1 - 4
 Parkview Rural Health Clinic Clinic/Center Medicare: Medicare Enrolled Practice Location: 307 East 9th Street, Wheeler, TX 79096 Phone: 806-826-0180 Fax: 806-826-0185 |
Luis L Mendiola Md Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 309 E 9th, Wheeler, TX 79096 Phone: 806-826-3576 Fax: 806-826-5201 |
Connaught Medical Practice Pllc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 307 East Ninth St, Wheeler, TX 79096 Phone: 806-826-2226 |
Adobe Walls Wellness Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 309 E 9th, Wheeler, TX 79096 Phone: 806-826-3581 Fax: 806-826-5279 |
News Archive
Isis receives $10 million from Biogen Idec to initiate IND-supporting studies of ISIS-BIIB3 Rx
Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec related to the initiation of investigational new drug (IND)-supporting studies of ISIS-BIIB3Rx. ISIS-BIIB3Rx is a recently identified development candidate designed to inhibit an undisclosed target to treat a neurodegenerative disease.
West Health Policy Center forms CIDSA to provide independent analysis of drug pricing policies
The West Health Policy Center, a nonprofit and nonpartisan policy research and education organization, announced today the formation of the Council for Informed Drug Spending Analysis, a group made up entirely of leading policy experts from the worlds of academia and healthcare.
Researchers identify urinary markers that predict bone problems in hip replacement patients
In a study published in the Journal of Orthopedic Research, investigators have identified urinary markers that differentiate total hip replacement patients who eventually develop bone tissue destruction, or osteolysis, from patients who do not.
CSI to present CALCIUM 360° Study results at TCT symposium
Cardiovascular Systems, Inc., announced today that its CALCIUM 360° Study, the first-of-its kind prospective, randomized feasibility study, demonstrated the safety and effectiveness of plaque modification with the Diamondback 360 PAD System versus the standard of care treatment (balloon angioplasty) in below-the-knee arteries.
Mallinckrodt, Actavis enter settlement agreement to resolve Exalgo patent litigation
Actavis, Inc. today announced that it has reached a settlement with Mallinckrodt Inc. on outstanding patent litigation related to Actavis' generic version of the 32 mg dosage strength of Mallinckrodt's Exalgo (Hydromorphone Hydrochloride Extended-Release) tablets.
› Verified 6 days ago